Why Are People Talking About Investing in ELAN?

By Emilio Sanchez • Friday, April 21 09:41 • Permanent Link

Join us for a quick overview of Elanco Animal Health, a Pharmaceutical company whose shares moved 0.8% today. Here are some facts about the stock that should help you see the bigger picture:

Elanco Animal Health has moved -61.5% over the last year, and the S&P 500 logged a change of -3.3%
ELAN has an average analyst rating of hold and is -32.62% away from its mean target price of $14.56 per share
Its trailing earnings per share (EPS) is $-0.16
Elanco Animal Health has a trailing 12 month Price to Earnings (P/E) ratio of -61.3 while the S&P 500 average is 15.97
Its forward earnings per share (EPS) is $0.9 and its forward P/E ratio is 10.9
The company has a Price to Book (P/B) ratio of 0.6 in contrast to the S&P 500's average ratio of 2.95
Elanco Animal Health is part of the Health Care sector, which has an average P/E ratio of 24.45 and an average P/B of 4.16
The company has a free cash flow of $330,124,992.00, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.